scispace - formally typeset
M

Maria Drobnjak

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  5
Citations -  3295

Maria Drobnjak is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Homologous recombination & Gene. The author has an hindex of 5, co-authored 5 publications receiving 3128 citations.

Papers
More filters
Journal ArticleDOI

A multigenic program mediating breast cancer metastasis to bone.

TL;DR: Overexpression of this bone metastasis gene set is superimposed on a poor-prognosis gene expression signature already present in the parental breast cancer population, suggesting that metastasis requires a set of functions beyond those underlying the emergence of the primary tumor.
Journal Article

17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/neu and Inhibits the Growth of Prostate Cancer Xenografts

TL;DR: It is demonstrated that, at a tolerable dose, inhibition of Hsp90 function by 17-AAG results in a marked reduction in HER2, AR, and Akt expression and inhibition of prostate tumor growth in mice, suggesting that this drug may represent a new strategy for the treatment of prostate cancer.
Journal Article

Cooperative Effects of p53 and pRB Alterations in Primary Superficial Bladder Tumors

TL;DR: Study of superficial transitional cell carcinomas of the urinary bladder by immunohistochemical analysis suggests that alterations of p53 and pRB have a cooperative negative effect on both progression and survival in primary bladder cancer.
Journal ArticleDOI

HDM2 Protein Overexpression and Prognosis in Primary Malignant Melanoma

TL;DR: HDRM2 overexpression appears to be an independent predictor of survival for patients with primary melanoma; however, larger prospective studies are required for validation.